Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors
Current Issues in Molecular Biology · 07.02.2023 · 45 (2) · 1422-1442
DOI: 10.3390/cimb45020093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 07.02.2023. Verfasst von Adel Alghamdi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Department, Faculty of Clinical Pharmacy, Al Baha University, Al Baha P.O. Box 1988, Saudi Arabia. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at the University of Ha’il, Saudi Arabia.
Abstract (Originalsprache)
Many biological activities of pyridine and thiazole derivatives have been reported, including antiviral activity and, more recently, as COVID-19 inhibitors. Thus, in this paper, we designed, synthesized, and characterized a novel series of N-aminothiazole-hydrazineethyl-pyridines, beginning with a N′-(1-(pyridine-3-yl)ethylidene)hydrazinecarbothiohydrazide derivative and various hydrazonoyl chlorides and phenacyl bromides. Their Schiff bases were prepared from the condensation of N-aminothiazole derivatives with 4-methoxybenzaldehyde. FTIR, MS, NMR, and elemental studies were used to identify new products. The binding energy for non-bonding interactions between the ligand (studied compounds) and receptor was determined using molecular docking against the SARS-CoV-2 main protease (PDB code: 6LU7). Finally, the best docked pose with highest binding energy (8a = −8.6 kcal/mol) was selected for further molecular dynamics (MD) simulation studies to verify the outcomes and comprehend the thermodynamic properties of the binding. Through additional in vitro and in vivo research on the newly synthesized chemicals, it is envisaged that the achieved results will represent a significant advancement in the fight against COVID-19.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Chemistry Department, Faculty of Clinical Pharmacy, Al Baha University, Al Baha P.O. Box 1988, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia.
- Department of Pharmaceutical Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, Egypt.
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia.
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
ORCID-Profile: Adel Alghamdi, Amr S Abouzied, Abdulwahab Alamri, Sirajudheen Anwar, Mukhtar Ansari, Ibrahim Khadra, Yasser H Zaki, Sobhi M Gomha
Förderung
- Scientific Research Deanship at the University of Ha’il, Saudi Arabia
Zitieren
APA
Alghamdi, A., Abouzied, A. S., Alamri, A., Anwar, S., Ansari, M., Khadra, I., Zaki, Y. H., & Gomha, S. M. (2023). Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors. Current Issues in Molecular Biology, 45(2), 1422-1442. https://doi.org/10.3390/cimb45020093
Vancouver
Alghamdi A, Abouzied AS, Alamri A, Anwar S, Ansari M, Khadra I, et al. Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors. Current Issues in Molecular Biology. 2023;45(2):1422-1442. doi:10.3390/cimb45020093
BibTeX
@article{Alghamdi2023,
author = {Alghamdi, Adel and Abouzied, Amr S and Alamri, Abdulwahab and Anwar, Sirajudheen and Ansari, Mukhtar and Khadra, Ibrahim and Zaki, Yasser H and Gomha, Sobhi M},
title = {Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors},
journal = {Current Issues in Molecular Biology},
year = {2023},
volume = {45},
number = {2},
pages = {1422--1442},
doi = {10.3390/cimb45020093}
}
EUVIMED